top of page

Strategized scientific content

 

that supports your CME programs

 
Virus Close-Up Illustration
dark blue background2.png

NSCLC

First-Line Erlotinib Versus Chemotherapy in EGFR-Mutated Advanced NSCLC

A slide deck targeting MedComm agencies based on Zhou, et al. OPTIMAL (CTONG-0802) phase 3 trial. Lancet Oncol. 2011.

dark blue background2.png

NSCLC

Post-Surgical Atezolizumab in Japanese NSCLC patients

An infographic targeting oncologists and pulmonologists in Japan, based on Kenmotsu, et al. IMpower010. Cancer Sci. 2022.

dark blue background2.png

SKIN MELANOMA

2021-2022 Management of Cutaneous Melanoma

Needs Assessment to submit to pharmaceutical sponsors (spec sample)

dark blue background2.png

SKIN MELANOMA

2022-2023 Management of Cutaneous Melanoma

A short Needs Assessment to submit to pharmaceutical sponsors (spec sample)

bottom of page